Research Article: PRMT Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma
Abstract:
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide and has increasing incidence and mortality. The pathophysiology of HCC involves in multistep processes. Owing to a lack of effective methods for early diagnosis, most HCC cases are diagnosed at an advanced stage., Currently, various therapies have been developed for the treatment of liver cancer, including combinations of radiotherapy, chemotherapy, hormonal therapy, and targeted therapy., In recent years, combinations of immunotherapy with targeted therapy have demonstrated practical clinical efficacy in HCC treatment. Post-translational modifications (PTMs), such as phosphorylation, acetylation, methylation, glycosylation, and ubiquitination have a major impact on protein function and have been shown to be associated with the development of various diseases including tumors, neurological diseases, and metabolic diseases.
Introduction:
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide and has increasing incidence and mortality. The pathophysiology of HCC involves in multistep processes. Owing to a lack of effective methods for early diagnosis, most HCC cases are diagnosed at an advanced stage. , Currently, various therapies have been developed for the treatment of liver cancer, including combinations of radiotherapy, chemotherapy, hormonal therapy, and targeted therapy. , In recent years, combinations of…
Read more